Regeneron signs $450M deal as part of 'Operation Warp Speed' for coronavirus antibody cocktail
One day after it started Phase III testing of an antibody cocktail that could be used for COVID-19 patients, Regeneron said it signed a $450 million deal with the U.S. government to make and supply the treatment.
No comments
Post a Comment